awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40863917-149C7EA1-A4DC-43BB-B3FD-0E294FFC5CEB
Q40863917-149C7EA1-A4DC-43BB-B3FD-0E294FFC5CEB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40863917-149C7EA1-A4DC-43BB-B3FD-0E294FFC5CEB
(90)Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study.
P921
Q40863917-149C7EA1-A4DC-43BB-B3FD-0E294FFC5CEB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40863917-149C7EA1-A4DC-43BB-B3FD-0E294FFC5CEB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
82630af7e1151e88e8ae34ab9d05aea66cb2f3b3
P921
leukemia